MISSISSAUGA, ON, May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the first quarter of 2024 after the market close on Thursday, May 9, 2024. The Company will also hold a conference call on Friday, May 10, 2024 at 8:30 ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
DATE: | May 10, 2024 |
TIME: | 8:30AM |
DIAL-IN NUMBER: | 416-764-8650 or 888-664-6383 |
REPLAY: | 416-764-8677 or 888-390-0541 Code:196164# |
Expires: May 17, 2024 | |
WEBCAST: |
Cipher Pharmaceuticals (TSX:CPH) (OTCQX:CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
| Last Trade: | C$15.73 |
| Daily Change: | -0.20 -1.26 |
| Daily Volume: | 79,778 |
| Market Cap: | C$399.380M |
August 07, 2025 May 08, 2025 April 29, 2025 November 07, 2024 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
